Quality of Life in African-American or Caucasian Female Breast Cancer Survivors
NCT ID: NCT00268502
Last Updated: 2015-11-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
195 participants
OBSERVATIONAL
2005-12-31
2014-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE: This clinical trial is studying the quality of life in African-American or Caucasian female breast cancer survivors.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance
NCT00309933
Peer Navigator Education in Improving Survivorship Care in African American Breast Cancer Survivors
NCT01450020
Quality of Life in Breast Cancer Patients and Survivors
NCT01272401
Survivor Stories: Impact on Cancer Patients' Quality of Life and Follow-up
NCT00929084
Breast Cancer Survivor Educational Intervention
NCT05700396
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Compare disease-specific, generic, and global quality of life measures in African-American survivors of breast cancer with Caucasian survivors of breast cancer.
* Compare these quality of life measures in African-American survivors of breast cancer with control group of African-American women with no history of breast cancer.
OUTLINE: Patients and healthy participants complete a battery of quality of life (QOL) questionnaires over approximately 65 minutes by mail or over the phone, including the Sexual Function Index, Functional Assessment of Cancer Therapy - Fatigue, Concerns About Recurrence Scale, and other measures of symptoms/side effects (including sleep problems), the RAND Physical Functioning -10 Scale, Center for Epidemiologic Studies - Depression Scale, assessment of family function/social support, ENRICH Marital Satisfaction Scale, Reed Spiritual Perspective Scale, assessments of coping and body image, Post-Traumatic Growth Inventory, and the Index of Well-being. Demographic, disease, treatment, and comorbidity information, as well as menstrual and gynecological history, work status and insurance history, and a measure of health care provider communication is collected using questionnaires and medical chart review.
PROJECTED ACCRUAL: A total of 195 patients and healthy participants will be accrued for this study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
study of socioeconomic and demographic variables
fatigue assessment and management
management of therapy complications
psychosocial assessment and care
quality-of-life assessment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Meets 1 of the following criteria:
* African-American or Caucasian breast cancer survivor
* Diagnosed with stage I-III breast cancer between the years of 1995-2003
* Receiving follow up care at the Indiana University Cancer Center (IUCC), the IUCC Northside Clinic, Spring Mill Clinic, or Wishard Memorial Hospital
* Healthy African-American
* Acquaintance of an African-American breast cancer survivor
* Not known to have breast cancer
PATIENT CHARACTERISTICS:
* Female
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
18 Years
120 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Indiana University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kathleen Russell, RN, DNS
Role: STUDY_CHAIR
Indiana University Melvin and Bren Simon Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CDR0000459904
Identifier Type: REGISTRY
Identifier Source: secondary_id
IUMC-0502-01B
Identifier Type: -
Identifier Source: secondary_id
IUMC-0209-08B
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.